Demand Cures Today

99¢ of every dollar received goes to fund cancer research

Cancer Research: Funded Clinical Trials

The Gateway’s research mission is to support patient-centered research that improves cancer treatment outcomes and restores the cancer patients’ quality of life. It is important to recognize that The Gateway funds research that benefits patients and not science alone.

Believing that the cancer patient’s best options are through an integrated oncology model, The Gateway supports innovative clinical research in conventional as well as complementary therapies. Read More »

  •  
Type of Cancer

Blood Cancer:
Lymphoma

CD3 Immunotoxin Therapy of CTCLArthur E. Frankel, MDFor patients with T-cell Lymphomas, this new agent molecule seeks and selectively destroys tumor cells with reduced injury to normal tissues compared to chemotherapy.
Scott and White Memorial Hospital

Active Trial

Accepting new patients? No More Information »

Blood Cancer:
Myeloma

Personalized Cancer Therapy: Lymphoma and MyelomaLarry W. Kwak, MDDr. Kwak is currently involved in a Gateway-funded Phase II clinical trial that involves a novel immune therapy for patients with difficult-to-treat blood cancers, such as myeloma....
MD Anderson Cancer Center, Houston, TX

Active Trial

Accepting new patients? Yes More Information »

Blood Cancer:
Myeloma

Powerful New Tools for Battling MyelomaDavid Avigan, MDCustom vaccines that stimulate the immune systems of cancer patients are being used with success by investigators. However, vaccines have their own limitations in activating the pa...
Beth Israel Deaconess Medical Center / Dana Farber-Harvard Cancer Center

Active Trial

Accepting new patients? Yes More Information »

Brain Cancer

Peptide Cancer Vaccine for Glioblastoma Pierre-Yves Dietrich, MD Glioblastoma (GBT) is the most prevalent and most aggressive form of cancers of the brain and nervous systems.  GBT is a dismal disease with one year survival rates at 30% and...
University Hospital Geneva

Active Trial

Accepting new patients? No More Information »

Brain Cancer

Predicting Brain Tumor RecurrenceDelphine Davis, MDSome types of brain cancer are inoperable and require other types of treatment. Trying to only kill cancer cells through radiation therapy is extremely difficult. Through new techn...
University of Rochester Medical Center

Active Trial

Accepting new patients? No More Information »

Breast Cancer

Innovative Vaccines to Combat Breast CancerLeisha Emens, MD, PhDVaccines are usually associated with prevention, but Dr. Emens’ research uses innovative vaccines to treat breast cancer patients. Dr. Emens’ approach focuses on genetically mo...
Johns Hopkins University School of Medicine

Active Trial

Accepting new patients? No More Information »

Cervical Cancer

Targeting Hormonal Triggers in Cervical Cancer Lois Ramondetta, MD The stress hormone noradrenaline fuels the growth and spread of aggressive malignant tumors. Previous studies suggest a new and potentially life-saving role for beta blockers, drug...
MD Anderson Cancer Center

Active Trial

Accepting new patients? No More Information »

Colorectal Cancer:
Colon / Rectal Cancer

Two-Step Therapy for Patients with Metastatic Colorectal CancerEdward Lin, MDA multi-center randomized phase II trial of ADAPT therapy vs standard of care for patients with metastatic colorectal cancer.
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA

Active Trial

Accepting new patients? No More Information »

Colorectal Cancer:
Colon / Rectal Cancer

Vitamin D Levels in Colorectal CancerKathleen Wesa, MDDetermine if it is clinically possible to achieve and maintain normal serum Vitamin D levels in patients with metastatic colon cancer on front-line treatment.
Sloan-Kettering Institute for Cancer Research

Active Trial

Accepting new patients? No More Information »

Lung Cancer

Combination Therapy for Advanced Non-Small Cell Lung CancerRichard Pietras, MD, PhD, & Lee Goodglick PhD, MBAThe basis for this study is the UCLA discovery that elevated estrogen levels are important fuel which induces lung cancer growth in both men and women. This study aims to stop NSCL...
UCLA Jonsson Cancer Center, Los Angeles, CA

Active Trial

Accepting new patients? Yes More Information »

Page 1 2 3 next »

Demand Cures Today Cancer Research

More About Our
Research

CANCER FACTS:

1,500 American people died today from cancer.

1,500 more will die tomorrow and the next day and the next...

Cancer Fact

Demanding it all!
Funding innovative cancer research for
Treatments. Cures. Life.